Eris Lifesciences Limited has been fined a total of ₹1.3 lakh by both BSE Limited and the National Stock Exchange of India Limited. Each exchange imposed a penalty of ₹65,000 on February 27, 2026, due to a non-compliance related to the completion of an Independent Director's term. The company stated that the non-compliance arose because the term of an Independent Director concluded. Eris Lifesciences is actively screening candidates to fill the anticipated vacancy and expects to report compliance soon. The company emphasized its commitment to adhering to all applicable laws and regulations. The financial impact of this penalty is limited to the total fine amount of ₹1.3 lakh. The company is taking steps to appoint a new Independent Director to rectify the composition of its Board of Directors.
